CharlesKoreKaufmanMD

Oncology • Saint Louis, MO

Hematologic Oncology, Melanoma

Instructor, Medicine-Brigham & Women's Hospital, Harvard Medical School

Join to view full profile

Dr. Kaufman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kaufman's full profile

Already have an account?

Office
5225 Mid America Plz
# Dv
Saint Louis, MO 63129
Phone+1 800-647-2098

Fax+1 314-362-3192

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2011
Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2007
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2005
University of ChicagoPhD, Molecular Genetics and Cell Biology, 1997 - 2003

Certifications & Licensure

MO State Medical License 2016 - 2025
MA State Medical License 2007 - 2018
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1 citations
Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer.
Ronald Fowle-Grider, Joe L Rowles 3rd, Isabel Shen, Yahui Wang, Michaela Schwaiger-Haber
Nature. 2024-12-01
Functional analysis of recurrent CDC20 promoter variants in human melanoma.
Paula M Godoy, Abimbola Oyedeji, Jacqueline L Mudd, Vasilios A Morikis, Anna P Zarov
Communications Biology. 2023-11-29
1 citations
Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism.
Jamison Leid, Ryan Gray, Peter Rakita, Andrew L Koenig, Rohan Tripathy
Biology Open. 2023-07-15

Press Mentions

Melanoma Research Alliance Announces $8.2 Million for 33 Grant Awards to Advance Melanoma ResearchApril 30th, 2019